The disclosure of transfers of values to Healthcare Professionals (HCP) and Healthcare Organisation (HCO) is part of the transparency initiative developed by the European Federation of Pharmaceutical Industries and Associations and the Forum of International research & development pharmaceutical companies, EIG.


Servier adheres and fully supports the objectives promoted through this self-regulatory initiative.


Pharmaceutical companies have to interact with the medical community in order to advance scientific knowledge and improve patient care. These interactions regularly imply important work/time/involvement from HCP and HCO, like for example the setting and follow up of clinical trials. The outcome of this publication will contribute to provide a better insight on our interactions.


The Forum of International research & development pharmaceutical companies, EIG proposes additional information on the publication principles followed by pharmaceutical companies locally.


For SLOVENIA, the publication of Servier’s transfers of values is available here:

2018

2019

2020

This publication has been prepared in accordance with the Slovene methodological note and the requirements of the Forum of International research & development pharmaceutical companies, EIG Code. The interactions listed in this document include all transfers of values made from 1st January to 31st December by all companies of the Servier Group, locally or from foreign countries.

You can contact us for any question in the information provided in this section and also find more information on the publication made by Servier in other countries.

In accordance with Code we disclose list of Patient Organizations to which Servier provided financial support: